tiprankstipranks
Trending News
More News >
Helix BioPharma (TSE:HBP)
TSX:HBP
Canadian Market

Helix BioPharma (HBP) Financial Statements

Compare
31 Followers

Helix BioPharma Financial Overview

Helix BioPharma's market cap is currently C$183.31M. The company's EPS TTM is C$-0.013; its P/E ratio is -29.02; Helix BioPharma is scheduled to report earnings on December 12, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -10.00KC$ -14.00KC$ -13.00KC$ -12.00KC$ -173.00K
Operating IncomeC$ -5.42MC$ -9.37MC$ -6.28MC$ -6.54MC$ -9.61M
EBITDAC$ -5.21MC$ -9.38MC$ -6.31MC$ -6.03MC$ -9.46M
Net IncomeC$ -5.21MC$ -9.26MC$ -6.29MC$ -6.08MC$ -7.91M
Balance Sheet
Cash & Short-Term InvestmentsC$ 65.00KC$ 1.08MC$ 808.00KC$ 3.25MC$ 3.56M
Total AssetsC$ 18.80MC$ 1.49MC$ 1.03MC$ 3.73MC$ 4.07M
Total DebtC$ 335.00KC$ 0.00C$ 0.00C$ 2.47MC$ 3.61M
Net DebtC$ 270.00KC$ -1.08MC$ -808.00KC$ -784.00KC$ 47.00K
Total LiabilitiesC$ 3.22MC$ 1.58MC$ 1.87MC$ 3.41MC$ 5.46M
Stockholders' EquityC$ 15.59MC$ -90.00KC$ -844.00KC$ 319.00KC$ -1.39M
Cash Flow
Free Cash FlowC$ -3.83MC$ -5.23MC$ -5.54MC$ -6.51MC$ -9.30M
Operating Cash FlowC$ -3.83MC$ -5.22MC$ -5.53MC$ -6.51MC$ -9.30M
Investing Cash FlowC$ 17.00KC$ -14.00KC$ -5.00KC$ 0.00C$ 2.02M
Financing Cash FlowC$ 2.80MC$ 5.51MC$ 3.09MC$ 6.21MC$ 6.56M
Currency in CAD

Helix BioPharma Earnings and Revenue History

Helix BioPharma Debt to Assets

Helix BioPharma Cash Flow

Helix BioPharma Forecast EPS vs Actual EPS